Acute Coronary SyndromeSyndromeAngina, UnstableMyelodysplastic SyndromesMyocardial InfarctionDown SyndromePlatelet Aggregation InhibitorsCoronary AngiographyCoronary VesselsCoronary Artery DiseaseNeoplasms, Second PrimaryPlatelet Glycoprotein GPIIb-IIIa ComplexGlaucoma, NeovascularAngioplasty, Balloon, CoronaryCoronary DiseaseAcute DiseaseMyocardial IschemiaElectrocardiographyAspirinHeparinAnticoagulantsTiclopidineChest PainCoronary ThrombosisCoronary CirculationBiological MarkersFibrinolytic AgentsRisk FactorsTreatment OutcomeHemorrhageCoronary StenosisTroponin TCoronary Artery BypassProspective StudiesAngina PectorisPercutaneous Coronary InterventionIschemiaMyocardial RevascularizationRisk AssessmentTroponin ITime FactorsPredictive Value of TestsPrognosisPurinergic P2Y Receptor AntagonistsFollow-Up StudiesPlaque, AtheroscleroticEnoxaparinCreatine Kinase, MB FormCoronary Care UnitsUltrasonography, InterventionalC-Reactive ProteinMetabolic Syndrome XCoronary VasospasmHeptanoic AcidsTroponinStentsAngina, StableHospitalizationHydroxymethylglutaryl-CoA Reductase InhibitorsThiophenesRecurrenceRetrospective StudiesRupture, SpontaneousCardiovascular AgentsRegistriesHirudinsAcetanilidesCoronary AneurysmThrombosisPyrrolesHospital MortalityCoronary RestenosisSeverity of Illness IndexRandomized Controlled Trials as TopicKaplan-Meier EstimateMultivariate AnalysisAngioscopyTriageCoronary OcclusionDrug Therapy, CombinationDouble-Blind MethodChi-Square DistributionHirudin TherapyCardiac CatheterizationCreatine KinaseProportional Hazards ModelsThrombolytic TherapyCohort StudiesPravastatinSensitivity and SpecificityCase-Control StudiesIncidencePlatelet ActivationLogistic ModelsAlbaniaNatriuretic Peptide, BrainSecondary PreventionNephrotic SyndromeVascular CalcificationROC Curve